hedychilactone A

Details

Top
Internal ID 68342083-875d-43d8-855a-7d82018a8968
Taxonomy Organoheterocyclic compounds > Lactones > Gamma butyrolactones
IUPAC Name (3E)-3-[2-[(1R,3S,4aS,8aS)-3-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]oxolan-2-one
SMILES (Canonical) CC1(CCCC2(C1CC(C(=C)C2CC=C3CCOC3=O)O)C)C
SMILES (Isomeric) C[C@]12CCCC([C@@H]1C[C@@H](C(=C)[C@@H]2C/C=C/3\CCOC3=O)O)(C)C
InChI InChI=1S/C20H30O3/c1-13-15(7-6-14-8-11-23-18(14)22)20(4)10-5-9-19(2,3)17(20)12-16(13)21/h6,15-17,21H,1,5,7-12H2,2-4H3/b14-6+/t15-,16-,17-,20+/m0/s1
InChI Key NTDYMFJJFRUEDG-LAABLSLUSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C20H30O3
Molecular Weight 318.40 g/mol
Exact Mass 318.21949481 g/mol
Topological Polar Surface Area (TPSA) 46.50 Ų
XlogP 4.20
Atomic LogP (AlogP) 4.02
H-Bond Acceptor 3
H-Bond Donor 1
Rotatable Bonds 2

Synonyms

Top
CHEMBL205885

2D Structure

Top
2D Structure of hedychilactone A

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9935 99.35%
Caco-2 + 0.6518 65.18%
Blood Brain Barrier + 0.5500 55.00%
Human oral bioavailability + 0.5286 52.86%
Subcellular localzation Mitochondria 0.7543 75.43%
OATP2B1 inhibitior - 0.8605 86.05%
OATP1B1 inhibitior + 0.8580 85.80%
OATP1B3 inhibitior + 0.9272 92.72%
MATE1 inhibitior - 0.8600 86.00%
OCT2 inhibitior + 0.5750 57.50%
BSEP inhibitior + 0.5959 59.59%
P-glycoprotein inhibitior - 0.7012 70.12%
P-glycoprotein substrate - 0.8395 83.95%
CYP3A4 substrate + 0.6459 64.59%
CYP2C9 substrate - 0.8032 80.32%
CYP2D6 substrate - 0.8757 87.57%
CYP3A4 inhibition - 0.5347 53.47%
CYP2C9 inhibition - 0.7878 78.78%
CYP2C19 inhibition - 0.7138 71.38%
CYP2D6 inhibition - 0.9195 91.95%
CYP1A2 inhibition - 0.7823 78.23%
CYP2C8 inhibition - 0.6903 69.03%
CYP inhibitory promiscuity - 0.8021 80.21%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.6097 60.97%
Eye corrosion - 0.9909 99.09%
Eye irritation - 0.8663 86.63%
Skin irritation + 0.5423 54.23%
Skin corrosion - 0.9376 93.76%
Ames mutagenesis - 0.6737 67.37%
Human Ether-a-go-go-Related Gene inhibition - 0.4001 40.01%
Micronuclear - 0.8600 86.00%
Hepatotoxicity - 0.5696 56.96%
skin sensitisation - 0.7155 71.55%
Respiratory toxicity + 0.6000 60.00%
Reproductive toxicity + 0.8222 82.22%
Mitochondrial toxicity + 0.8875 88.75%
Nephrotoxicity + 0.4918 49.18%
Acute Oral Toxicity (c) III 0.7368 73.68%
Estrogen receptor binding + 0.6473 64.73%
Androgen receptor binding + 0.6523 65.23%
Thyroid receptor binding + 0.6466 64.66%
Glucocorticoid receptor binding + 0.7967 79.67%
Aromatase binding + 0.5982 59.82%
PPAR gamma + 0.6060 60.60%
Honey bee toxicity - 0.7850 78.50%
Biodegradation - 0.6250 62.50%
Crustacea aquatic toxicity - 0.5800 58.00%
Fish aquatic toxicity + 0.9948 99.48%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.64% 91.11%
CHEMBL253 P34972 Cannabinoid CB2 receptor 95.02% 97.25%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 93.85% 95.56%
CHEMBL2581 P07339 Cathepsin D 92.40% 98.95%
CHEMBL1994 P08235 Mineralocorticoid receptor 89.71% 100.00%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 89.20% 82.69%
CHEMBL3137262 O60341 LSD1/CoREST complex 86.60% 97.09%
CHEMBL1293249 Q13887 Kruppel-like factor 5 83.92% 86.33%
CHEMBL4040 P28482 MAP kinase ERK2 82.82% 83.82%
CHEMBL1806 P11388 DNA topoisomerase II alpha 82.44% 89.00%
CHEMBL3145 P42338 PI3-kinase p110-beta subunit 81.48% 98.75%
CHEMBL1977 P11473 Vitamin D receptor 81.23% 99.43%
CHEMBL218 P21554 Cannabinoid CB1 receptor 80.68% 96.61%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 80.68% 94.45%

Cross-Links

Top
PubChem 10041596
NPASS NPC50488
LOTUS LTS0053204
wikiData Q105185404